Get all your news in one place.

100’s of premium titles.
One app.

Get all your news in one place.

100’s of premium titles. One news app.

The Latest Breaking News from Sacklers

The threat of litigation looms as Purdue Pharma returns to settlement talks

OxyContin maker Purdue Pharma, the family that owns it and lawyers for thousands of parties with claims against it are getting ready to work on a new settlement after the U.S. Supreme Court rejected the last one

The Independent UK

US Supreme Court Rejects Opioid Settlement That Shields Sackler Family

The US Supreme Court on Thursday rejected Purdue Pharma's $6 billion opioids settlement immunizing the Sackler family, which controlled the drugmaker, from future litigation.

International Business Times

Supreme Court rejects settlement with OxyContin maker Purdue Pharma over legal protections for the Sackler family that owned the company

The Supreme Court ruled 5-4 against an estimated US$6 billion Purdue Pharma bankruptcy plan on June 27, 2024, that would have shielded the Sackler family – which owned and controlled the company – from legal liability.

The Conversation

From analysis to the latest developments in health,
read the most diverse news in one place.

SCOTUS Reverses Purdue Pharma Opioid Settlement, Threatening Billions For Victims

The ruling dealt a blow to Purdue Pharma's bankruptcy reorganization plan, which aimed to allocate billions of dollars to victims of opioid addiction while shielding the Sackler family from future lawsuits.

International Business Times

US Supreme Court rejects $6 billion OxyContin settlement shielding Sackler family

The US Supreme Court on Thursday rejected OxyContin maker Purdue Pharma's $6 billion settlement that would have shielded the Sackler family, who owned the company and earned tens of billions as it flooded the country with the highly addictive drug, from future civil lawsuits over the role they played in…

France 24

The legal odyssey for OxyContin maker Purdue Pharma and its owners is complex. Here's what to know

The Supreme Court has rejected a settlement for OxyContin maker Purdue Pharma and members of the Sackler family who own the company

The Independent UK

US supreme court blocks Purdue Pharma’s bankruptcy settlement that would shield Sacklers from lawsuits

Controversial deal would have protected billionaire family owners from further liability over US opioid epidemic

The Guardian - US

Read news from The Economist, FT, and more,
with one subscription

The Supreme Court rejects a nationwide opioid settlement with OxyContin maker Purdue Pharma

The Supreme Court has rejected a nationwide settlement with OxyContin maker Purdue Pharma that would've shielded Sackler family members who own the company from civil lawsuits over the toll of opioids but also would've provided billions of dollars to combat the epidemic

The Independent UK

Best films of 2023 in the UK: No 9 – All the Beauty and the Bloodshed

Laura Poitras’s powerful documentary follows artist Nan Goldin on a successful crusade to publicise America’s opioids crisis

The Guardian - UK

Divided US High Court Hears Challenge To $6bn Purdue Opioid Settlement

The US Supreme Court appeared divided on Monday as it heard a challenge to Purdue Pharma's $6 billion opioids settlement immunizing the Sackler family that controlled the drugmaker from future litigation.

International Business Times

The Sackler family wants protection from opioid lawsuits. Will the Supreme Court grant it?

A bankruptcy case before the Supreme Court could grant the Sackler family immunity from opioid-related civil cases Ariana Baio reports

The Independent UK

Purdue Pharma, Sacklers' OxyContin settlement lands at the Supreme Court

Under the deal, Purdue agreed it owed $8 billion in criminal and civil fines. That deal is at the center of Monday's case because it releases the Sacklers from personal liability.

WEKU

OxyContin maker bankruptcy deal goes before the Supreme Court on Monday, with billions at stake

The Supreme Court is hearing arguments over a nationwide settlement with OxyContin maker Purdue Pharma that would shield members of the Sackler family who own the company from civil lawsuits over the toll of opioids

The Independent UK

US High Court To Hear Challenge To $6bn Purdue Opioid Settlement

The US Supreme Court is to hear a challenge on Monday to Purdue Pharma's $6 billion opioids settlement immunizing the family that controlled the drugmaker from future litigation.

International Business Times

Get all your
news in one place.

100’s of premium titles.
One news app.

Marie Claire

Will Netflix Renew 'Painkiller' for Season 2?

Though 'Painkiller' comes to an end after six episodes, both the opioid epidemic and the legal battle against Purdue Pharma and the Sacklers are still ongoing.

GoodToKnow

Where is Richard Sackler now? Whereabouts of the former Perdue Pharma president explained

Where is Richard Sackler now? Whereabouts of the former Perdue Pharma president and the Sackler family net worth explained.

Marie Claire

The True Story Behind 'Painkiller,' From Richard Sackler to Purdue Pharma

The scripted miniseries covers all angles of the opioid epidemic

The Guardian - US

US court move to reassess Sackler deal ‘opens window’ for victims’ families

Sackler family members had been granted immunity from civil claims via $6bn settlement but activists hope that could change

Get all your
news in one place.

100’s of premium titles.
One news app.

Woman & Home

Is Netflix's Painkiller based on a true story? The inspiration behind the gripping new series

Here's what you need to know about the real Sackler family...

Zenger

Supreme Court Halts Purdue Pharma’s $6B Settlement From A Challenge In A Lawsuit

The Supreme Court temporarily blocked a bankruptcy settlement by Purdue Pharma that would shield victims from civil lawsuits.

WEKU

Supreme Court temporarily blocks $6 billion Purdue Pharma-Sackler bankruptcy

Supreme Court's decision to review the controversial bankruptcy deal involving the maker of Oxycontin means the settlement will remain on hold at least through December.

Evening Standard

Painkiller on Netflix review: this drama exploring America’s opioid crisis feels achingly real

This show skilfully captures the impossible emotional complexity of loving an addict

The Independent UK

Painkiller review: The harrowing story of the opioid crisis has been told much more movingly elsewhere

Matthew Broderick stars as Purdue Pharma head Richard Sackler in this thinly written Netflix drama about the rise of Oxy – ‘Dopesick’ did it better

The Guardian - UK

Painkiller review – Matthew Broderick’s character is just evil

The actor’s role as the head of the company behind the opioid crisis isn’t the most rewarding, but this drama is furious, unflinching TV. Its horrifying story should be heard again and again

Reason

Short Circuit: A Roundup of Recent Federal Court Decisions

Bridges to nowhere, a blindfolded surprise, and a threatening smirk.

1 2 3

People

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

the Justice Department

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.